ELVN short interest
Enliven Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 10,356,282 |
|---|---|
| Change vs prior report | 1,735,779 (+20.1%) |
| Change over six months | +71.1% |
| Days to cover | 5.49 (sector: 3.78) |
| Average daily volume | 1,887,497 |
| Rank in Healthcare | #371 of 922 by days to cover |
ELVN short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 10,356,282 | +20.1% | 5.49 | 1,887,497 |
| 2026-09-15 | 8,620,503 | +0.2% | 9.01 | 956,494 |
| 2026-08-31 | 8,600,289 | +4.1% | 11.07 | 776,607 |
| 2026-08-14 | 8,258,991 | +1.3% | 6.33 | 1,304,405 |
| 2026-07-31 | 8,151,554 | -5.8% | 11.44 | 712,367 |
| 2026-07-15 | 8,651,596 | +1.5% | 9.41 | 919,272 |
| 2026-06-30 | 8,527,025 | +57.1% | 3.09 | 2,755,836 |
| 2026-06-15 | 5,426,405 | +4.1% | 2.61 | 2,079,224 |
| 2026-05-29 | 5,213,383 | +1.8% | 8.73 | 597,268 |
| 2026-05-15 | 5,122,350 | -2.9% | 8.05 | 636,686 |
| 2026-04-30 | 5,273,791 | -1.9% | 6.86 | 768,825 |
| 2026-04-15 | 5,374,014 | -11.2% | 4.28 | 1,254,668 |
| 2026-03-31 | 6,053,456 | -26.3% | 2.86 | 2,117,376 |
| 2026-03-13 | 8,215,500 | +3.0% | 10.54 | 779,453 |
| 2026-02-27 | 7,979,674 | -1.2% | 12.26 | 650,975 |
| 2026-02-13 | 8,078,549 | +2.6% | 11.21 | 720,452 |
| 2026-01-30 | 7,870,182 | -14.1% | 7.89 | 997,280 |
| 2026-01-15 | 9,166,736 | +10.3% | 4.19 | 2,190,049 |
| 2025-12-31 | 8,312,949 | +2.5% | 11.85 | 701,388 |
| 2025-12-15 | 8,111,262 | +1.4% | 9.81 | 826,728 |
| 2025-11-28 | 7,996,827 | +2.6% | 14.74 | 542,671 |
| 2025-11-14 | 7,794,126 | +0.1% | 10.37 | 751,520 |
| 2025-10-31 | 7,782,638 | +21.2% | 18.19 | 427,946 |
| 2025-10-15 | 6,422,840 | +12.7% | 15.53 | 413,696 |
| 2025-09-30 | 5,699,585 | +17.4% | 8.22 | 693,643 |
import finzdata as yf
yf.Ticker("ELVN").short_interest # every report since 2017
yf.Client().short_interest(["ELVN"], start="2018-01-01")Healthcare short interest · ELVN price history · Who owns ELVN · All short interest